|
MCM3APAS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.129800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.647600E-01 |
| Normal-vs-Stage2 |
3.963000E-01 |
| Normal-vs-Stage3 |
1.529730E-02 |
| Normal-vs-Stage4 |
9.095600E-02 |
| Stage1-vs-Stage2 |
9.560200E-01 |
| Stage1-vs-Stage3 |
8.553600E-02 |
| Stage1-vs-Stage4 |
3.648000E-01 |
| Stage2-vs-Stage3 |
1.987000E-01 |
| Stage2-vs-Stage4 |
4.699200E-01 |
| Stage3-vs-Stage4 |
6.052800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.813900E-02 |
| Normal-vs-AfricanAmerican |
9.646200E-01 |
| Normal-vs-Asian |
4.672800E-01 |
| Caucasian-vs-AfricanAmerican |
9.325900E-02 |
| Caucasian-vs-Asian |
9.965200E-01 |
| AfricanAmerican-vs-Asian |
5.681800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.621800E-02 |
| Normal-vs-Female |
3.411000E-01 |
| Male-vs-Female |
1.643980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.270800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.683800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.888000E-02 |
| Normal-vs-Age(81-100Yrs) |
8.234200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.088200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.200800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.218200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.886400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.427000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.644000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.526400E-01 |
| Normal-vs-Grade 2 |
1.792040E-01 |
| Normal-vs-Grade 3 |
1.251220E-01 |
| Normal-vs-Grade 4 |
3.244600E-03 |
| Grade 1-vs-Grade 2 |
9.594000E-02 |
| Grade 1-vs-Grade 3 |
1.427990E-01 |
| Grade 1-vs-Grade 4 |
9.760900E-03 |
| Grade 2-vs-Grade 3 |
6.819400E-01 |
| Grade 2-vs-Grade 4 |
2.152500E-02 |
| Grade 3-vs-Grade 4 |
6.960300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.908000E-01 |
| Normal-vs-ccB subtype |
1.872080E-02 |
| ccA subtype-vs-ccB subtype |
1.427790E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.475900E-02 |
| Normal-vs-N1 |
1.742000E-03 |
| N0-vs-N1 |
3.074400E-02 |
|
|
